Transfection refers to the introduction of foreign DNA into bacterial and/or mammalian cells. It is an important tool used in studies investigating gene function and the modulation of gene expression, thus contributing to the advancement of basic cellular research, drug discovery, and target validation. Transfection technologies are widely used in cell research, recombinant protein production, drug discovery, gene therapy and therapeutics. Transfection can be accomplished using chemical, biological, or physical methods. Common methods include electroporation, the use of a virus vector, lipofection, and biolistics. Many types of genetic material, including plasmid DNA, siRNA, proteins, dyes, and antibodies, may be transfected using any of these methods. However, a single method cannot be applied to all types of cells; transfection efficiencies and cytotoxicity may vary dramatically and depend on the method, cell type being utilized, and types of experiments being performed. Therefore, to obtain high efficiencies, all relevant factors should be considered for planning and selecting the appropriate transfection method.
The global transfection technologies market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).
The global transfection technologies market segmentation is based on transfection methods (instrument based method, electroporation, biolistic technology, microinjection, laserfection, reagent based method, lipid mediated transfection, calcium phosphate, catonic polymers, DEAE-dextran, activated dendrimers, magnetic beads, virus based method), and its applications (biomedical research, transgenic models, cancer research, gene and protein expression studies, cell based microarrays for drug discovery and development, therapeutic delivery, biotherapeutics, electro-chemotherapy and electro-immunotherapy, protein production).
The global transfection technologies market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global transfection technologies market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global transfection technologies market and included in this report are Bio-Rad Laboratories Inc., Lonza Group Ltd., QIAGEN, Promega Corporation Sigma Aldrich Corporation, SignaGen Laboratories, and Thermo Fisher Scientific (Life Technologies Corporation).